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REVIEW IN DEPTH
Clinical pathophysiology of hibernating myocardium
Gerrit D. Dispersyn, Frans C. S. Ramaekers and Marcel Borgers
Our current knowledge of the pathophysiology of chronic
hibernating myocardium is mainly based on results from
clinical studies, because of the absence of appropriate
and validated animal models. These clinical observations
have given rise to two major controversies: the role of
reduced blood flow and that of histological changes in
the hibernating segments. In this review, these two
subjects will be briefly discussed, and put into the
perspective of findings emerging from recently
developed animal models. Coron Artery Dis
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Introduction
In patients with coronary artery disease, chronic re-
versible left ventricular contractile dysfunction, often
referred to as ‘chronic hibernating myocardium’, is a
frequently encountered clinical entity. The reduced left
ventricular function in this setting is thought to be an
adaptive response to inadequate myocardial perfusion.
In this way the myocardium adjusts its metabolic de-
mand to meet the decreased supply, and thus preserves
 its viability and prevents irreversible injury 1 . Al-
though the concept of hibernating myocardium has an
important clinical impact, its underlying pathophysio-
logical mechanisms are largely unknown. Because of the
absence of appropriate animal models, current
knowledge of chronic hibernating myocardium in man
is mainly based on the results of clinical studies, and
has led to two major controversies. The ﬁrst controversy
relates to whether the functional abnormalities are a
result of chronically reduced myocardial perfusion, on
the one hand, or of repetitive episodes of acute is-
chemia despite normal resting perfusion on the other,
that is, whether or not chronic hibernation actually
represents chronic repetitive stunning. The second con-
troversy results from the ﬁnding of complex structural
changes, both cellular and extracellular, in the human
hibernating myocardium. Given the severity of these
structural changes, it is likely that they affect contractile
function. It is, however, not clear whether or not these
Ž .structural changes are adaptive and thus reversible .
Some observations suggest that they represent the ﬁrst
stage of a degenerative pathway, leading to irreversible
 damage 2 . In this review, the most important recent
ﬁndings regarding these two controversies will be brieﬂy
focused on.
Histopathology of chronic hibernating
myocardium
Several structural abnormalities can be found in trans-
mural needle biopsies from chronic hibernating myo-
cardium, taken during coronary bypass surgery.
Concerning cellular changes, perinuclear sarcomere de-
pletion is found in a substantial number of cardiomy-
ocytes, which however do not become atrophic, but
instead increase their volume by accumulating glycogen
in the sarcomere-depleted perinuclear areas. These cells
also display numerous small and abnormally shaped
mitochondria, have nuclei with homogeneously dis-
persed heterochromatin, and lose their well-organized
 sarcoplasmic reticular system 3 . These changes mean
that such cardiomyocytes adopt features that resemble
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the fetal phenotype, and suggest that cellular dediffer-
entiation has taken place. This has been conﬁrmed by
the ﬁnding of an embryonicfetal expression pattern of
several proteins, such as titin, desmin, cardiotin, and the
re-expression of -smooth muscle actin in these car-
 diomyocytes 4 . It has been suggested that this process
of dedifferentiation represents a kind of programmed
cell survival: the cells are transformed from an energy-
consuming active contractile phenotype to an energy-
 saving acontractile phenotype 5 . Indeed, an increased
tolerance of dedifferentiated cells to acute ischemia
with preservation of mitochondrial oxidative phosphory-
 lation has been shown 6 . Moreover, the role of glyco-
gen storage could have a similar role as in cardiomy-
ocytes during cardiac development, where it has been
suggested that glycogen storage plays a crucial role in
maintaining a certain degree of turgor, necessary for cell
 survival 7 .
It is likely, although not proven, that these structural
changes are reversible. This is suggested by the re-
versible nature of contractile dysfunction. Because the
structural changes are unlikely to be immediately re-
versible, it is hypothesized that the delay in recovery of
function is at least partly attributable to these structural
 abnormalities 8,9 . However, it must be stressed that
both the contribution of the structural changes to the
functional abnormalities, and the contribution of the
hypothesized reversibility of these changes to the recov-
ery of function, remain to be established. Although it is
possible that the functional abnormalities are indepen-
dent from the structural changes, the recent ﬁnding that
the rate of functional recovery correlates with the per-
centage of structurally altered cardiomyocytes, strongly
 favors such a relationship 9 .
The trigger for cardiomyocyte dedifferentiation is un-
known. Although dedifferentiated cardiomyocytes are
consistently found in biopsies from patients with chronic
reversible left ventricular dysfunction, it is not a unique
feature of chronic hibernating myocardium. Indeed, the
same cellular changes are found in several other car-
diomyopathies, such as volume and pressure overload
   10 , chronic atrial ﬁbrillation in humans 11 and goats
   12 , in infarct border zones 13 , and in explanted
 failing hearts 14 . A common factor in both chronic
hibernation and several of these other cardiomyopathies
in which cardiomyocyte dedifferentiation is found, is an
increased dilatation of the left ventricular or atrial wall.
Ž .It is therefore suggested that moderate cellular stretch
might be involved in triggering cardiomyocyte dedif-
ferentiation. Hibernation-like dedifferentiation charac-
teristics are found in cultured adult rabbit cardiomy-
 ocytes undergoing transient and repetitive stretch 15 .
These ﬁndings suggest at least that a decreased oxygen
availability is not per se necessary for triggering dedif-
ferentiation. That increased preload-induced stretch
may play a role in the induction of the histopathological
changes is also suggested in a pig model of chronic
hibernating myocardium, in which cardiomyocyte ded-
ifferentiation was not only found in the regions with
reduced perfusion, but to a similar extent in the remote
 areas 16 . Conversely, an acute disassembly of myoﬁb-
rils  possibly preceding the myolysis accompanying
dedifferentiation  was found in both the ischemic and
normally perfused remote areas in a model of prolonged
partial coronary artery occlusion in chronically instru-
 mented dogs 17 .
Apart from myolysis, a possible alternative explanation
for the contractile dysfunction has been suggested in an
 investigation by Shan et al. 18 , reporting that a changed
adrenoreceptor density in hibernating myocardium
might also be involved in the mechanism of depressed
myocardial function. They found that in patients with
hibernating myocardium an increase in density of -
adrenergic receptor and a decreased -adrenergic recep-
tor density could be detected in viable segments, al-
though, as is the case for cellular changes, a causeef-
fect relation is not proven. Nevertheless, this ﬁnding is
important in unraveling the pathophysiology of chronic
hibernation, and deserves further attention. Another
relevant observation made in chronic hibernating my-
ocardium in patients, which might explain the initiation
and the maintenance of the contractile dysfunction,
concerns the altered cellcell interaction through defec-
 tive gap junctions 19 .
Apart from cellular changes, extracellular alterations are
also present in chronic hibernating myocardium. Even
in carefully selected patients, excluding the ones with
prior myocardial infarction, an increase in interstitial
 ﬁbrosis can be found 20 . Without other patient selec-
tion criteria, however, the amount of interstitial ﬁbrosis
varies enormously, suggesting that in many patients
Ž .micro- infarctions coexist with hibernating segments
 21 . It was found that the contractile reserve and the
function after reperfusion are inversely correlated with
   the amount of ﬁbrosis 22,23 . Nagueh et al. 23 found
Žthat viable segments identiﬁed by dobutamine
.echocardiography , which recovered function after coro-
nary bypass surgery  thus being truly hibernating
Ž .segments  had less ﬁbrosis 2.54.7% than segments
Ž .that did not recover 10.38.4% . The amount of
ﬁbrosis in the truly hibernating segments corresponds
with earlier ﬁndings in meticulously selected patients
 3 . The ﬁnding of increased amounts of ﬁbrosis together
with an incomplete recovery of function in such patients
is suggestive of the occurrence of replacement ﬁbrosis
caused by myocyte loss. Therefore, a causal relationship
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between cardiomyocyte dedifferentiation and apoptosis
has been suggested by some investigators, thereby con-
sidering dedifferentiation as a kind of pro-apoptotic
 state 21 . However, it cannot be excluded that hiber-
nation-like adaptational changes occur in the surviving
border zone of infarcts, so that in some patients hiber-
nation is the consequence rather than the cause of
increased ﬁbrosis. In favor of this hypothesis is the
experimental ﬁnding that dedifferentiating cardiomy-
ocytes appear in border zones of micro-embolization-
 induced micro-infarctions 13,24 . This might also ex-
plain the occurrence of cardiomyocyte cell death through
apoptosis in porcine models of prolonged acute is-
chemia, in which signiﬁcant necrosis was also present.
Indeed, apoptosis is known to contribute to both acute
and subacute cell death in infarctions. The latter mod-
els may be the experimental equivalent of patients with
hibernating myocardium in which high levels of ﬁbrosis
and ultrastructural evidence of apoptosis were found
 21 . Nevertheless, in pigs with chronically decreased
coronary ﬂow reserve, which show physiological features
of hibernating myocardium without necrosis, an in-
crease in subendocardial apoptosis was found, next to a
 minimal increase in connective tissue 25 . Interest-
ingly, cardiomyocyte dedifferentiation and apoptosis
were found in both areas with decreased coronary re-
serve as well as in normally perfused remote areas,
although to a lesser extent in the latter. In patients in
which myocardial infarction was meticulously excluded,
only a minimal increase of connective tissue and no
 evidence of cardiomyocyte apoptosis was found 26 .
These ﬁndings suggest that there is no causal relation-
ship between cardiomyocyte dedifferentiation and
apoptosis, but instead, that apoptosis is a temporal
phenomenon occurring only at a certain stage in the
development of hibernating myocardium. It can be
hypothesized that at an early stage of progression of the
abnormalities in function or perfusion, only part of the
cell population is capable of adopting a protective
phenotype, while the rest dies through apoptosis. In
favor of this hypothesis are the ﬁndings that in the
aforementioned porcine model the percentages of apop-
tosis peaked at 3 months after induction of the de-
 creased coronary reserve 27 and that in infarct border
zones dedifferentiated and apoptotic cardiomyocytes
 presumably belong to different cell populations 28 .
This hypothesis would also be in line with the sugges-
tion that cardiomyocyte dedifferentiation might even
 represent a form of programmed cell survival 5,29 .
Apart from the ﬁndings that dedifferentiated cardiomy-
ocytes are more ischemia tolerant than normally struc-
 tured counterparts 6 , its has recently been shown that
endogenous protective mechanisms, such as increased
expression of the stress protein HSP-70, are induced in
cardiomyocytes in an experimental model of chronic
 hibernation 30 . Moreover, in pigs with hibernating
myocardium, adenosine triphosphate and creatine phos-
phate levels were similar in dysfunctional and remote
 areas 31 . Undoubtedly, the development of repro-
ducible animal models for chronic hibernating my-
ocardium, without confounding necrosis, is of crucial
importance to further unravel these issues, and might
provide us with a clear insight into the role of cardiomy-
ocyte dedifferentiation and apoptosis in hibernating my-
ocardium.
Flow in chronic hibernating myocardium
In its original deﬁnition, chronic hibernating my-
ocardium was described as being characterized by a
chronic and severe resting myocardial blood ﬂow. How-
ever, unlike the situation in acute ischemia where there
is a close coupling between regional myocardial func-
tion and subendocardial blood ﬂow, several studies have
indicated that in the case of chronic hibernation, the
decrease in blood ﬂow is not as severe or permanent as
 originally thought 32,33 . Using quantitative positron
Ž .emission tomography PET , most of the more recent
Ž  .studies reviewed in 34 suggest either a normal or
only moderately decreased blood ﬂow in the dysfunctio-
nal regions. This would implicate that chronic repetitive
ischemia and subsequent overlapping periods of stun-
ning are at the basis of hibernating myocardium. It
should be noted that in patient studies only relative
differences in ﬂow are evaluated, that is, in the same
patient the ﬂow in the dysfunctional areas is compared
to the ﬂow in remote non-dysfunctional regions in which
Žan increased ﬂow according to the increased compen-
.satory function could be present. However, quantita-
tive analysis of ﬂow in the non-dysfunctional areas in
patients and ﬂow in normal volunteers resulted in simi-
 lar values 33 . Whereas transmural differences in histo-
logical changes have consistently been demonstrated,
the presence of transmural differences in blood ﬂow,
although expected, is not shown by PET because of the
limited spatial resolution of this imaging technique.
Observations in an experimental model of hibernating
myocardium have indeed suggested the existence of
such a transmural difference, the decrease in blood ﬂow
being most pronounced in the subendocardial layers
 35 . Based on these and clinical studies, it is likely that
chronic reversible dysfunctional myocardium can be the
consequence of both sustained and repetitive underper-
 fusion. Shen and Vatner 36 showed that chronic stun-
ning can be at the basis of chronic dysfunctional my-
ocardium in an experimental model where necrosis is
absent and histologically identiﬁed hibernating my-
ocardium present. In the dysfunctional regions, baseline
blood ﬂow was normal, and multiple episodes of de-
mand ischemia during excitement and subsequent stun-
ning were observed. The effect of repetitive stunning
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was cumulative, resulting in continuously dysfunctional
myocardium. Using a reproducible model of chronic
coronary stenosis resulting in viable chronically dysfunc-
 tional myocardium, Fallavollita et al. 35 have proposed
that chronic stunning and chronic hibernation form a
continuum. Initially, repetitive ischemia caused chronic
stunning, while resting blood ﬂow in these dysfunctio-
nal regions was normal. This situation lasted for up to 2
months, but after 3 months, the blood ﬂow at rest is
reduced in the dysfunctional areas, leading to the physi-
ologic ﬁndings of hibernating myocardium. The transi-
tion from stunning to hibernation seemed to occur at
the time of a critical reduction in the coronary ﬂow
reserve caused by a progressive increase in stenosis
severity. Moreover, it has been shown that an acceler-
ated progression from stunning to hibernation can be
induced in less than 2 weeks, when without an initial
reduction in resting perfusion, an acute critical reduc-
 tion in coronary ﬂow reserve is produced 27 . Based on
clinical data and the ﬁndings from experimental animal
models, it is clear that viable chronically dysfunctional
myocardium in patients can represent chronic stunning,
chronic hibernation or a combination of both. Possibly a
correlation exists between the underlying mechanism
Ž .stunning or hibernation , the degree of dysfunction,
the degree of histological change, and the time frame of
recovery of function after revascularization. Further re-
search using reproducible animal models of viable
chronically dysfunctional myocardium will be needed to
elucidate this issue.
Conclusion
Based on the currently available clinical and experimen-
tal data it is obvious that viable chronically dysfunctio-
nal myocardium is likely to be caused by different
pathophysiological mechanisms, and moreover is often
confounded by the presence of irreversibly damaged
tissue, from which it is not clear whether it occurs as a
consequence of chronic dysfunction, or whether it is a
preceding or even unrelated event. This makes a proper
interpretation of the data difﬁcult. Fortunately, several
reproducible animal models are emerging, which will
deﬁnitely contribute to a more adequate understanding
and interpretation of the clinical counterpart.
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